EditorialPolicy
Translational research and the U.S. federal elections
- Jonathan Kimmelman and
- Aaron S. Kesselheim
- Jonathan Kimmelman, Studies of Translation, Ethics and Medicine (STREAM), Biomedical Ethics Unit, McGill University, Montréal, Québec H3A 1X1, Canada. Email: jonathan.kimmelman{at}mcgill.ca
- Aaron S. Kesselheim, Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham Women’s Hospital, Harvard Medical School, Boston, MA 02120, USA.
See allHide authors and affiliations
Science Translational Medicine 19 Oct 2016:
Vol. 8, Issue 361, pp. 361ed13
DOI: 10.1126/scitranslmed.aah5233
Vol. 8, Issue 361, pp. 361ed13
DOI: 10.1126/scitranslmed.aah5233
Jonathan Kimmelman
Jonathan Kimmelman, Studies of Translation, Ethics and Medicine (STREAM), Biomedical Ethics Unit, McGill University, Montréal, Québec H3A 1X1, Canada. Email: